Through our partnership with Alkem Laboratories, we are committed to achieving our vision of a sustainable and equitable healthcare system, enriching quality of life in patients’ lives. Alkem Laboratories supports our business by developing novel generic formulations, allowing us to provide non-infringing generics to Australia patients.
Alkem Laboratories have a team of over 500 highly specialised researchers stationed across six different R&D centres in India and the USA. Their researchers power the development of generics, bio similars, transdermal drug delivery systems, oral films, and technology intensive products like Novel Drug Delivery Systems (NDDS) that are difficult to produce. Below is a list of our research facilities with their locations:
Alkem Laboratories have a team of over 500 highly specialised researchers stationed across six different R&D centres in India and the USA. Their researchers power the development of generics, bio similars, transdermal drug delivery systems, oral films, and technology intensive products like Novel Drug Delivery Systems (NDDS) that are difficult to produce. Below is a list of our research facilities with their locations:
Our R&D Centre has developed products and filed over 140 ANDAs with USA FDA, close to 60 products with TGA Australia, around 30 products for EU and many dossiers in other countries including Brazil, South Africa, Canada, Chile and rest of the world. Our research capabilities has paid dividends not only in terms of business but with an enviable reputation for quality and capability.